Business Context and Reporting Period
This Form 8-K filing by Acadia Healthcare Company, Inc. reports significant corporate governance changes effective December 16, 2018. The filing details the removal of the former Chief Executive Officer (CEO) and Chairman of the Board, and the subsequent appointment of new leadership.
Key Financial Metrics
The filing does not provide operational financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The financial data presented is limited to the compensation terms of the newly appointed CEO, Ms. Debbie Osteen:
- Annual Base Salary: $900,000
- Target Annual Bonus: 100% of base salary ($900,000)
- 2019 Long-Term Incentive Target: Not less than $3.2 million
- Sign-on Cash Bonus: $350,000
- Sign-on Equity Grant (RSUs): Grant date fair value not exceeding $6.65 million
- Additional Cash Payment: $2.5 million payable on the first anniversary of the Effective Date
- Relocation and Living Expense Reimbursement: Up to $8,000 per month for 12 months and up to $225,000 for relocation expenses
Material Changes Versus Prior Period
The primary material change is the complete turnover of the company's top executive leadership and board chairmanship:
- Departure: Mr. Joey A. Jacobs was removed from his positions as CEO and Chairman of the Board.
- CEO Appointment: Ms. Debbie Osteen was elected CEO. She previously led the Behavioral Health Division of Universal Health Services, Inc.
- Chairman Appointment: Mr. Reeve B. Waud, formerly the lead director since April 2012, was elected Chairman of the Board.
- Board Expansion: The Board of Directors was expanded from eight to nine directors to accommodate Ms. Osteen's election as a director.
Guidance, Outlook, and Management Commentary
The filing does not contain financial guidance, operational outlook, or general management commentary regarding future business performance. The document focuses exclusively on the terms of the new employment agreement and the structural changes to the Board. Key contractual terms include:
- Employment Term: December 16, 2018, through December 31, 2020.
- Severance Provisions: In the event of termination without "cause" or resignation for "good reason," Ms. Osteen is entitled to accrued salary, pro-rated bonuses, a lump sum equal to one year of base salary plus target bonus, and 18 months of health insurance premiums.
- Relocation Requirement: Ms. Osteen is required to permanently relocate to Nashville within 12 months.
Important Facts for Investor Verification
- Verify the strategic rationale for replacing the CEO and Chairman, as the filing does not disclose the reasons for Mr. Jacobs' removal.
- Assess the impact of the significant one-time compensation costs (approximately $13.7 million in total value including equity and cash) on the company's near-term cash flow and earnings.
- Review the full text of the Employment Agreement (Exhibit 10.1) for specific definitions of "cause" and "good reason" which trigger substantial severance payments.
- Monitor the integration of Ms. Osteen's leadership style and her background in behavioral health operations at Universal Health Services.